Posts by: Alice Melão, MSc

News

CSA Medical‘s RejuvenAir System has been granted CE Mark approval in Europe for treating people with chronic obstructive pulmonary disease (COPD) who have chronic bronchitis — frequent inflammation of the ... Read more

December 6, 2019December 6, 2019

Zephyr Valve Favored as Standard of Care for Eligible COPD Patients in 2020 GOLD Report

News

The Global Initiative for Chronic Obstructive Disease (GOLD) recommends the use of endobronchial valves — such as the Zephyr Valve — for bronchoscopic lung volume reduction (BLVR) as a standard ... Read more

November 12, 2019November 12, 2019

Non-invasive Test to Diagnose Genetic Form of COPD Now Available in U.S.

News

AlphaID, a cheek swab test that can help identify patients with chronic obstructive pulmonary disease (COPD) who have the disease due to alpha-1 antitrypsin deficiency (AATD), is now available ... Read more

November 8, 2019November 8, 2019

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

News

A new public-private initiative brings academic and industry researchers from 15 European countries together in a large-scale effort to understand differences and commonalities in seven immune-mediated and inflammatory diseases, including ... Read more

November 1, 2019November 1, 2019

Seasonal Variations of COPD Exacerbations Call for Timely Preventive Measures, Study Suggests

News

Patients with chronic obstructive pulmonary disease (COPD) often have more acute episodes of symptom worsening (exacerbations) during the coldest months of the year — January, February, and March — ... Read more

October 22, 2019October 22, 2019

Spirometry After Bronchodilator Treatment Improves Diagnosis Accuracy, Study Shows

News

Routine evaluation of respiratory function through spirometry after treatment with bronchodilator medicines can help improve diagnosis accuracy for chronic obstructive pulmonary disease (COPD), preventing approximately 39% of overdiagnosis, a ... Read more

October 4, 2019October 4, 2019

Dorney-Koppel Foundation Spotlights COPD at Stanford Medicine X | CHANGE Conference

News

The Dorney-Koppel Family Charitable Foundation put chronic obstructive pulmonary disease in the spotlight, leading the educational grand challenge at the recent Stanford Medicine X | CHANGE 2019 conference. This ... Read more

July 12, 2019July 12, 2019

Macrolide Antibiotics May Reduce Acute Exacerbations in COPD Patients, Review Study Suggests

News

Long-term use of low-dose macrolide antibiotics is safe and potentially effective in reducing acute exacerbations in younger patients with chronic obstructive pulmonary disease (COPD) who are at risk for ... Read more

March 29, 2019March 29, 2019

UK Trial to Assess Beta-blocker’s Ability to Lessen Flares in COPD Patients Now Enrolling

News

People with chronic obstructive pulmonary disease (COPD) are being asked to participate in a U.K. clinical study evaluating how well bisoprolol, a common beta-blocker to treat high blood pressure, works in preventing pulmonary ... Read more

March 19, 2019March 19, 2019

Mice Studies Suggest Cathepsin S to Prevent Lung Inflammation in COPD, CF

News

Activation of PP2A enzyme with consequent modulation of cathepsin S levels may represent a new strategy to prevent chronic obstructive pulmonary disease (COPD), a mice study shows. This finding ... Read more

Posts by: Alice Melão, MSc

Alice Melão, MSc

RejuvenAir System Granted CE Mark Approval in Europe to Treat COPD With Chronic Bronchitis

Zephyr Valve Favored as Standard of Care for Eligible COPD Patients in 2020 GOLD Report

Non-invasive Test to Diagnose Genetic Form of COPD Now Available in U.S.

European 3TR Project Unites Experts in Effort to Make Treatment More Personal and Effective

Seasonal Variations of COPD Exacerbations Call for Timely Preventive Measures, Study Suggests

Spirometry After Bronchodilator Treatment Improves Diagnosis Accuracy, Study Shows

Dorney-Koppel Foundation Spotlights COPD at Stanford Medicine X | CHANGE Conference

Macrolide Antibiotics May Reduce Acute Exacerbations in COPD Patients, Review Study Suggests

UK Trial to Assess Beta-blocker’s Ability to Lessen Flares in COPD Patients Now Enrolling

Mice Studies Suggest Cathepsin S to Prevent Lung Inflammation in COPD, CF

Pin It on Pinterest